Cargando…
Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice
Fibromyalgia (FM) is a complex pathology described as persistent hyperalgesia including somatic and mood dysfunctions, depression and anxiety. Although the etiology of FM is still unknown, a significant decrease in biogenic amines is a common characteristic in its pathogenesis. Here, our main object...
Autores principales: | Martins, Carlos Pereira, Paes, Rodrigo Sebben, Baldasso, Gabriela Mantovani, Ferrarini, Eduarda Gomes, Scussel, Rahisa, Zaccaron, Rubya Pereira, Machado-de-Ávila, Ricardo Andrez, Silveira, Paulo Cesar Lock, Dutra, Rafael Cypriano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463993/ https://www.ncbi.nlm.nih.gov/pubmed/34269222 http://dx.doi.org/10.4103/1673-5374.317984 |
Ejemplares similares
-
Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
por: Deutschländer, Angela, et al.
Publicado: (2016) -
Pioglitazone improves skeletal muscle functions in reserpine-induced fibromyalgia rat model
por: Hassan, Fatma E., et al.
Publicado: (2021) -
Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy Volunteers
por: Kaltenboeck, Alexander, et al.
Publicado: (2022) -
Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D(3 )receptor
por: Joyce, Jeffrey N, et al.
Publicado: (2004) -
Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats
por: Favero, Gaia, et al.
Publicado: (2017)